About Journal

Welcome to the International Journal of Cardiodiabetes (IJCD), an innovative and comprehensive resource that explores the interplay between cardiovascular disease and diabetes. We are proud to be a part of Rila Publications Ltd (UK) and to carry on the vision of our late founder, Professor Avijit (Tultul) Lahiri, who recognized the crucial connection between these two prevalent conditions.

Our mission at IJCD is to provide a platform for cutting-edge research, insightful reviews, and expert perspectives on the complex relationship between cardiovascular disease and diabetes, a phenomenon now commonly called “Cardiodiabetes.” By fostering scientific understanding and clinical advancements, we aim to contribute to the improvement of patient care and promote prevention strategies on a global scale.

The IJCD welcomes submissions from a diverse range of professionals, including cardiologists, diabetologists, general practitioners, public health experts, and metabolic medicine specialists. Our journal features primary research, systematic reviews, and clinical reviews, ensuring a well-rounded and informative experience for our readers.

We are dedicated to fostering a vibrant community of professionals passionate about Cardiodiabetes, and we encourage open dialogue and exchange of ideas. As such, we welcome contributions to our correspondence section, providing a space for thought-provoking discussions and debates.

With your support, we believe that the International Journal of Cardiodiabetes can become the leading clinical research journal in the field, positively impacting the lives of millions of individuals affected by Cardiodiabetes worldwide. Together, we can make a difference in the fight against this ever-growing global health challenge.

The IJCD is looking always looking to receive submissions for editorial review, and these can be uploaded at: https://submissions.rila.co.uk/index.php/ijc/login

Join us in our journey to advance knowledge, improve patient care, and encourage prevention in the realm of Cardiodiabetes.

Scroll to Top